FDA Brief

Warning letters Drugs

FDA warning letter to

Botanicals Internacional S.A. de C.V.

High riskIssued Feb 3, 2021Posted Feb 9, 2021Center for Drug Evaluation and Research | CDER

Botanicals Internacional's inatek hand sanitizer was found to contain methanol instead of labeled ethanol and was refused at U.S. border.

What happened

FDA laboratory testing of a batch of inatek HAND SANITIZER detained at the U.S. border found an average of 75% methanol and 0.2% ethyl alcohol, although the label declared 70% ethyl alcohol. FDA also found the product was an unapproved new drug and misbranded, and placed drugs from the firm on Import Alert 66-78.

What FDA found

  1. The labeled active ingredient ethyl alcohol was substituted wholly or partly with methanol, a dangerous chemical.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The substitution showed that quality assurance at the facility was not working as required by current good manufacturing practice (CGMP).

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer was marketed as a new drug without FDA approval.

    FD&C Act section 505(a), 21 U.S.C. 355(a); sections 301(d), 21 U.S.C. 331(d)
  4. The product was misbranded because it was dangerous to health when used according to its label.

    FD&C Act section 502(j), 21 U.S.C. 352(j)
  5. The label was false and misleading because it declared 70% ethyl alcohol even though the product contained much less and also contained undisclosed methanol.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  6. The label did not list methanol as an ingredient, and the product did not meet the nonprescription drug marketing requirements in section 505G.

    FD&C Act sections 502(e)(1)(A) and 502(ee), 21 U.S.C. 352(e)(1)(A) and 352(ee)

What FDA wants

FDA tells the firm to respond in writing within 15 working days with an updated methanol-substitution investigation, corrective and preventive actions, a list of all hand sanitizer batches shipped to the U.S., full batch records, raw material and supplier lists, and an explanation of why its quality systems failed. FDA also recommends a qualified consultant audit the entire operation before the firm seeks to resume U.S. drug manufacturing.

Who should pay attention

  • brands or distributors that buy hand sanitizer from this manufacturer
  • retailers and consumers who may encounter inatek HAND SANITIZER
  • importers and contract manufacturers of alcohol-based hand sanitizers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk